Visual field after anti-vascular endothelial growth factor therapy and laser treatment for retinopathy of prematurity

Revised Indications for the Treatment of Retinopathy of Prematurity

Archives of Ophthalmology · 2003 · 1.6K citations

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

Helen A. Mintz-Hittner, Kathleen A. Kennedy, Alice Z. Chuang · New England Journal of Medicine · 2011 · 1.4K citations · Full text

Refractive Outcomes Following Bevacizumab Monotherapy Compared With Conventional Laser Treatment

Megan M. Geloneck, Alice Z. Chuang, W. Lloyd Clark et al. · JAMA Ophthalmology · 2014 · 319 citations

Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings

Domenico Lepore, Graham E. Quinn, Fernando Molle et al. · Ophthalmology · 2017 · 127 citations

Type 1, Ocular Disease, Fluorescein Angiographic Findings +6

Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity Study: Findings at 4 to 6 years of age

Graham E. Quinn, Velma Dobson, Bradley V. Davitt et al. · Journal of American Association for Pediatric Ophthalmology and Strabismus · 2013 · 122 citations · Full text

Ocular Disease, High Myopia, Ophthalmology +7